Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma.
Garinet S, Didelot A, Marisa L, Beinse G, Sroussi M, Le Pimpec-Barthes F, Fabre E, Gibault L, Laurent-Puig P, Mouillet-Richard S, Legras A, Blons H. Garinet S, et al. Among authors: didelot a. J Transl Med. 2023 May 15;21(1):324. doi: 10.1186/s12967-023-04086-7. J Transl Med. 2023. PMID: 37189151 Free PMC article.
Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC.
Garinet S, Didelot A, Denize T, Perrier A, Beinse G, Leclere JB, Oudart JB, Gibault L, Badoual C, Le Pimpec-Barthes F, Laurent-Puig P, Legras A, Blons H. Garinet S, et al. Among authors: didelot a. Br J Cancer. 2021 Nov;125(11):1544-1551. doi: 10.1038/s41416-021-01568-7. Epub 2021 Oct 12. Br J Cancer. 2021. PMID: 34642464 Free PMC article.
Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer.
Pécuchet N, Laurent-Puig P, Mansuet-Lupo A, Legras A, Alifano M, Pallier K, Didelot A, Gibault L, Danel C, Just PA, Riquet M, Le Pimpec-Barthes F, Damotte D, Fabre E, Blons H. Pécuchet N, et al. Among authors: didelot a. Oncotarget. 2017 Apr 4;8(14):23831-23840. doi: 10.18632/oncotarget.6379. Oncotarget. 2017. PMID: 26625312 Free PMC article.
Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.
Pécuchet N, Zonta E, Didelot A, Combe P, Thibault C, Gibault L, Lours C, Rozenholc Y, Taly V, Laurent-Puig P, Blons H, Fabre E. Pécuchet N, et al. Among authors: didelot a. PLoS Med. 2016 Dec 27;13(12):e1002199. doi: 10.1371/journal.pmed.1002199. eCollection 2016 Dec. PLoS Med. 2016. PMID: 28027313 Free PMC article.
Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer.
Legras A, Pécuchet N, Imbeaud S, Pallier K, Didelot A, Roussel H, Gibault L, Fabre E, Le Pimpec-Barthes F, Laurent-Puig P, Blons H. Legras A, et al. Among authors: didelot a. Cancers (Basel). 2017 Aug 3;9(8):101. doi: 10.3390/cancers9080101. Cancers (Basel). 2017. PMID: 28771186 Free PMC article. Review.
The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
Mansuet-Lupo A, Bobbio A, Blons H, Becht E, Ouakrim H, Didelot A, Charpentier MC, Bain S, Marmey B, Bonjour P, Biton J, Cremer I, Dieu-Nosjean MC, Sautès-Fridman C, Régnard JF, Laurent-Puig P, Alifano M, Damotte D. Mansuet-Lupo A, et al. Among authors: didelot a. Chest. 2014 Sep;146(3):633-643. doi: 10.1378/chest.13-2499. Chest. 2014. PMID: 24676429
63 results